Correlation Between CHC Healthcare and Apex Biotechnology
Can any of the company-specific risk be diversified away by investing in both CHC Healthcare and Apex Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CHC Healthcare and Apex Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CHC Healthcare Group and Apex Biotechnology Corp, you can compare the effects of market volatilities on CHC Healthcare and Apex Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CHC Healthcare with a short position of Apex Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of CHC Healthcare and Apex Biotechnology.
Diversification Opportunities for CHC Healthcare and Apex Biotechnology
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CHC and Apex is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding CHC Healthcare Group and Apex Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apex Biotechnology Corp and CHC Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CHC Healthcare Group are associated (or correlated) with Apex Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apex Biotechnology Corp has no effect on the direction of CHC Healthcare i.e., CHC Healthcare and Apex Biotechnology go up and down completely randomly.
Pair Corralation between CHC Healthcare and Apex Biotechnology
Assuming the 90 days trading horizon CHC Healthcare Group is expected to under-perform the Apex Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, CHC Healthcare Group is 1.28 times less risky than Apex Biotechnology. The stock trades about 0.0 of its potential returns per unit of risk. The Apex Biotechnology Corp is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 2,915 in Apex Biotechnology Corp on September 26, 2024 and sell it today you would earn a total of 110.00 from holding Apex Biotechnology Corp or generate 3.77% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
CHC Healthcare Group vs. Apex Biotechnology Corp
Performance |
Timeline |
CHC Healthcare Group |
Apex Biotechnology Corp |
CHC Healthcare and Apex Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CHC Healthcare and Apex Biotechnology
The main advantage of trading using opposite CHC Healthcare and Apex Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CHC Healthcare position performs unexpectedly, Apex Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apex Biotechnology will offset losses from the drop in Apex Biotechnology's long position.CHC Healthcare vs. Phytohealth Corp | CHC Healthcare vs. GenMont Biotech | CHC Healthcare vs. Hung Sheng Construction | CHC Healthcare vs. De Licacy Industrial |
Apex Biotechnology vs. Grape King Bio | Apex Biotechnology vs. Standard Chemical Pharmaceutical | Apex Biotechnology vs. China Steel Chemical | Apex Biotechnology vs. Sinphar Pharmaceutical Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Transaction History View history of all your transactions and understand their impact on performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |